3352 (2025). Hon Jo Luxton to the Minister for Food Safety

Written Question

Published date: 19 Feb 2025

Metadata

Document type:	Written Question
Parliament number:	54
Question number:	3352 (2025)
Question asked:	04 Feb 2025
Member asking:	Hon Jo Luxton
Portfolio:	Minister for Food Safety
Minister replying:	Hon Andrew Hoggard
Answer received:	13 Feb 2025
Status:	Question Answered
Reply type:	Reply
Document ID:	WQ_03352_2025
Document guid:	196fed13-fafb-4384-972a-3265989c59fa

3352 (2025). Hon Jo Luxton to the Minister for Food Safety: What, if any, are the risks if the agricultural compounds and veterinary medicines (ACVM) approval process shifts from requiring statistically significant results and larger sample sizes to relying on qualitative efficacy claims with fewer animals in trials, and how, if at all, will animal welfare and food safety standards be maintained under this new approach?

Hon Andrew Hoggard: Qualitative efficacy trial work still requires a statistically significant result such as compared to a control. In addition, the Agricultural Compounds and Veterinary Medicines Act 1997 (ACVM) requirements for residues (food safety) and target animal safety (animal welfare) remain the same to manage associated risks.